DOSE EQUATIONS WITHOUT PROTEIN-BINDING PARAMETERS

被引：0
|
作者：
OTOZAI, K [1 ]
OTAYA, H [1 ]
机构：
[1] JAPAN & SHIONOGI PHARMACEUT CO LTD,OSAKA,JAPAN
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY | 1978年 / 16卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：463 / 466
页数：4
相关论文
共 50 条
  • [1] EFFECT OF PROTEIN-BINDING ON STEADY-STATE EQUATIONS
    WAGNER, JG
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1985, 13 (05): : 559 - 560
  • [2] DOSE-DEPENDENCY OF THEOPHYLLINE CLEARANCE AND PROTEIN-BINDING
    FLEETHAM, JA
    BIRD, CE
    NAKATSU, K
    WIGLE, RD
    MUNT, PW
    THORAX, 1981, 36 (05) : 382 - 386
  • [3] DOSE-DEPENDENCY OF THEOPHYLLINE CLEARANCE AND PROTEIN-BINDING
    FLEETHAM, JA
    BIRD, CE
    NAKATSU, K
    WIGLE, RD
    MUNT, PW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1979, 119 (04): : 112 - 112
  • [4] PHARMACOKINETICS AND PROTEIN-BINDING OF HIGH-DOSE ETOPOSIDE
    SCHWINGHAMMER, TL
    FLEMING, RA
    ROSENFELD, CS
    SHADDUCK, RK
    STEWART, CF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 195 - 195
  • [5] COMPETITIVE PROTEIN-BINDING ASSAY OF PROGESTERONE WITHOUT CHROMATOGRAPHY
    PICHON, MF
    MILGROM, E
    STEROIDS, 1973, 21 (03) : 335 - 346
  • [6] PROTEIN-BINDING OF GLISOXEPIDE AND ITS INFLUENCE ON PROTEIN-BINDING OF PHENPROCOUMON
    SCHLOSSMANN, K
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1974, 24 (3A): : 392 - 397
  • [7] IMPLICATIONS OF DOSE REGIMEN AND PROTEIN-BINDING FOR PLASMA NORTRIPTYLINE ESTIMATIONS
    STEVENSON, IH
    WILSON, NM
    SCHIFF, AA
    NEUROPHARMACOLOGY, 1978, 17 (06) : 423 - 426
  • [8] DOSE-DEPENDENT PROTEIN-BINDING AND DISPOSITION OF PREDNISOLONE IN RABBITS
    ROCCI, ML
    JUSKO, WJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (11) : 1201 - 1204
  • [9] THYROID ANTIBODIES AND PROTEIN-BINDING OF THYROXINE IN PATIENTS WITH AND WITHOUT THYROTOXICOSIS
    BANOS, C
    TAKO, J
    GYORGYI, S
    JUHASZ, J
    SZTRAKA, I
    KAPUS, I
    ENDOKRINOLOGIE, 1973, 61 (01): : 32 - 36
  • [10] PROTEIN-BINDING OF WARFARIN
    LEVY, G
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (02) : 211 - 211
12345